Gene · 11034
Papers1,526
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,526
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study. | EClinicalMedicine | 2023 | 37457113 | PubTator, text mining | PubMed |
| Distinct functional constraints driving conservation of the cofilin N-terminal regulatory tail. | bioRxiv | 2023 | 37425676 | PubTator, text mining | PubMed |
| Circulating and non-circulating proteins and nucleic acids as biomarkers and therapeutic molecules in ovarian cancer. | Genes Dis | 2023 | 37396515 | PubTator, text mining | PubMed |
| Targeting lysine-specific demethylase 1 (KDM1A/LSD1) impairs colorectal cancer tumorigenesis by affecting cancer cells stemness, motility, and differentiation. | Cell Death Discov | 2023 | 37385999 | PubTator, text mining | PubMed |
| High Level of GMFG Correlated to Poor Clinical Outcome and Promoted Cell Migration and Invasion through EMT Pathway in Triple-Negative Breast Cancer. | Genes (Basel) | 2023 | 37372337 | PubTator, text mining | PubMed |
| SPECC1L: a cytoskeletal protein that regulates embryonic tissue dynamics. | Biochem Soc Trans | 2023 | 37345651 | PubTator, text mining | PubMed |
| Leveraging a disulfidptosis-based signature to improve the survival and drug sensitivity of bladder cancer patients. | Front Immunol | 2023 | 37325625 | PubTator, text mining | PubMed |
| Membrane trafficking in breast cancer progression: protein kinase D comes into play. | Front Cell Dev Biol | 2023 | 37293129 | PubTator, text mining | PubMed |
| Declining trends in vaccine confidence across sub-Saharan Africa: A large-scale cross-sectional modeling study. | Hum Vaccin Immunother | 2023 | 37290478 | PubTator, text mining | PubMed |
| Hedonic and eudaimonic well-being for sustainable development in university students: personality traits or acceptance of change? | Front Psychol | 2023 | 37255512 | PubTator, text mining | PubMed |
| Dopaminergic Modulation of Prefrontal Cortex Inhibition. | Biomedicines | 2023 | 37238947 | PubTator, text mining | PubMed |
| Mass Spectrometry-Based Proteomics of Epithelial Ovarian Cancers: A Clinical Perspective. | Mol Cell Proteomics | 2023 | 37209814 | PubTator, text mining | PubMed |
| Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy. | Explor Target Antitumor Ther | 2023 | 37205317 | PubTator, text mining | PubMed |
| Hospital-based clinicians lack knowledge and comfort in initiating medications for opioid use disorder: opportunities for training innovation. | Addict Sci Clin Pract | 2023 | 37198707 | PubTator, text mining | PubMed |
| HUNK inhibits epithelial-mesenchymal transition of CRC via direct phosphorylation of GEF-H1 and activating RhoA/LIMK-1/CFL-1. | Cell Death Dis | 2023 | 37193711 | PubTator, text mining | PubMed |
| Biomolecules Involved in Both Metastasis and Placenta Accreta Spectrum-Does the Common Pathophysiological Pathway Exist? | Cancers (Basel) | 2023 | 37174083 | PubTator, text mining | PubMed |
| A prognostic model for bladder cancer based on cytoskeleton-related genes. | Medicine (Baltimore) | 2023 | 37115085 | PubTator, text mining | PubMed |
| TRAP1 S-nitrosylation as a model of population-shift mechanism to study the effects of nitric oxide on redox-sensitive oncoproteins. | Cell Death Dis | 2023 | 37085483 | PubTator, text mining | PubMed |
| Development of three-dimensional primary human myospheres as culture model of skeletal muscle cells for metabolic studies. | Front Bioeng Biotechnol | 2023 | 37034250 | PubTator, text mining | PubMed |
| Getting cells into shape by calcium-dependent actin cross-linking proteins. | Front Cell Dev Biol | 2023 | 37025173 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11034/papers?page=6